Historic Event Unites 22 Late-Stage Cancer Survivors with Top Scientists From Around the World!

  Last November, CHIPSA Hospital hosted a unique, first-of-its-kind event celebrating the lives of 22 late stage cancer survivors who, according to doctors, shouldn’t even be alive. Surrounded by world-renowned doctors, scientists, and researchers, these patients shared their inspiring stories of how they healed their terminal disease when conventional treatment had failed them.     […]

Continue reading

What Causes a Durable Cancer Remission?

Cancer relapse is unfortunately all too common in patients who were told their disease was eradicated. We’ve all heard of the patient who receives a clear diagnosis, only to be stricken with cancer yet again.   Why is it that the cancer came back?   Why didn’t the remission last?   This is exactly what […]

Continue reading

Keytruda Now FDA-Approved for Patients with Melanoma


The KEYNOTE-054 Phase 3 clinical trial (NCT02362594) showed that the immune checkpoint inhibitor drug Keytruda decreased the risk of melanoma recurrence or death by 43% in comparison to a placebo drug. The drug has thus been approved by the U.S. Food and Drug Administration (FDA) to treat patients with stage-3 melanoma (cancer has spread to […]

Continue reading